Epidemiological study of chronic mountain sickness in natives of spiti valley in the greater himalayas

High Altitude Medicine and Biology

Volumn 14, Issue 3, 2013, Pages 220-229

  Negi, Prakash Chand ^a   Asotra, Sanjeev ^a   Ravi Kumar, V ^a   Marwah, Rajeev ^a   Kandoria, Arvind ^a   Ganju, Neeraj Kumar ^a   Sharma, Rajesh ^a   Bhardwaj, Rajeev ^a  

^a Department of Cardiology   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTITUDE; ALTITUDE DISEASE; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HUMAN; HYPOXEMIA; INDIA; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POLYCYTHEMIA; PREVALENCE; PRIORITY JOURNAL; QINGHAI CRITERIA;

ADULT; AGE FACTORS; ALTITUDE; ALTITUDE SICKNESS; ANOXIA; ASIAN CONTINENTAL ANCESTRY GROUP; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; ERYTHROCYTE COUNT; FEMALE; FORCED EXPIRATORY VOLUME; HEMOGLOBINS; HUMANS; INDIA; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY, ABDOMINAL; OXYGEN; POLYCYTHEMIA; PREVALENCE; SEX FACTORS; VITAL CAPACITY;

EID: 84884765111     PISSN: 15270297     EISSN: 15578682     Source Type: Journal    
DOI: 10.1089/ham.2012.1127     Document Type: Article

References (34)

1. Chinese Medical Association for high altitude medicine. (1996). Recommendations for the classification and diagnostic criteria for high altitude disease in China. Chin High Alt Med J (Chin). 6:2-5.
2. Consensus Statement by ad hoc committee of the international society for mountain medicine on chronic high altitude diseases. (2004). Sixth world congress on mountain medicine and high altitude physiology. Aug 12-15, Xining, Qinghai, China. 5-10.
3. Beall CM. (2000). Tibetan and Andean patterns of adaptation to high altitude hypoxia. Hum Biol 72:201-228.
4. Ekici A, Ekici M, Kurtipek E, et al. (2005). Obstructive airway diseases in women exposed to biomass smoke. Environ Res 99:93-98.
5. Enrique Vargas P, and Spielvogel H. (2006). Chronic mountain sickness, optimal hemoglobin, and heart disease. High Alt Med Biol 7:138-149.
6. Ge RL, Shai HR, and Chen QH. (1995). Changes of red cell 2,3- diphosphoglycerate and oxygen affinity of blood in subjects with high altitude polycythemia. Chin J Appl Physiol (Chin) 11:205-208.
7. Heath D, and Williams DR. (1981). Man at High Altitude. Churchill Livingston, London and New York.
8. Kryger MH, and Grover RF. (1983). Chronic mountain sickness. Semin Respir Med 5:164-168.
9. Leon Velarde F, Arregui A, Monge CC, Ruiz Y, and Ruiz H. (1993). Aging at high altitude and the risk of chronic mountain sickness. J Wild Med 4:183-188.
10. Leon-Velarde F, Ramos MA, Hernandez JA, et al. (1997). The role of menopause in the development of chronic mountain sickness. Am J Physiol Reg Integ Comp Physiol 272:R90-R94.
11. Leon-Velarde F, Maria Rivera-Ch, Tapia L, Huicho, and Monge CC. (2001). Relationship of ovarian hormones to hypoxemia in women residents of 4,300 m. Am J Physiol Reg Integ Comp Physiol 280:R488-R493.
12. Leon-Velarde F, Maggiorini M, Reeves JT, et al. (2005). Consensus statement on chronic and subacute high altitude disease. High Alt Med Biol 6:147-157.
13. Maria Rivera-Ch, Leon-Velarde F, and Luis Huicho. (2007). Treatment of chronic mountain sickness: Critical reappraisal of an old problem. Resp Physiol Neurobiol 158:251-265.
14. Monge CC, Arregui A, and Leon Velarde F. (1992). Pathophysiology and epidemiology of chronic mountain sickness. Int J Sports Med 13:S79-S81.
15. Moore LG. (2001). Human genetic adaptation to high altitude. High Alt Med Biol 2:257-279.
16. Pei SX, Cheng XJ, Si Ren BZ, et al. (1989). Chronic mountain sickness in Tibet. Q J Med 71:555-574.
17. Penaloza D, and Sime F. (1971). Chronic cor pulmonale due to loss of altitude acclimatization (chronic mountain sickness). Am J Med 50:728-743.
18. Penaloza D, Sime F, and Ruiz L. (1971). Cor pulmonale in chronic mountain sickness. Present concept of Monge's disease. In: High Altitude Physiology: Cardiac and Respiratory Aspects. Porter R, and Knight J, eds. Churchill Livingstone, Edinburgh and London; pp.41-60.
19. Regalado J, Perez-Padilla R, Sansores R, et al. (2006). The effect of biomass burning on respiratory symptoms and lung function in rural Mexican women. Am J Respir Crit Care Med 174:901-905.
20. Richalet JP, Rivera M, Bouchet P, et al. (2005). Acetazolamide: A treatment of chronic mountain sickness. Am J Respir Crit Care Med 172:1427-1433.
21. Richalet JP, Rivera Chira M, Maignan M, et al. (2008). Acetazolamide for Monge's disease. Efficiency and tolerance of a 6 month treatment. Am J Respir Crit Care Med 177:1370-1376.
22. Sime F, Monge CC, and Whittembury J. (1975). Age as a cause of chronic mountain sickness (Monge's disease). Int J Biometerol 19:93-98.
23. Weitz CA, and Ralph MG. (2007). A comparative analysis of arterial oxygen saturation among Tibetans and Han born and raised at high altitude. High Alt Med Biol 8:13-26.
24. Winslow RM, and Monge CC. (1987). Hypoxia, Polycythemia, and Chronic Mountain Sickness. The Johns Hopkins University Press, Baltimore and London, pp. 17-18.
25. Wu TY. Zhang Q, Die TF, and Jin BS. (1987). Chronic mountain sickness occurring in Tibetan Natives [in Chinese]. Natl Med J China (Chin) 67:167-168.
26. Wu TY, Zhang Q, Jin BS, Xu F, Cheng Q, and Wang XZ. (1992). Chronic mountain sickness (Monge's disease). An observation in Qinghai - Tibet plateau. In: High Altitude Medicine. Ueda G, Reeves J.T, Sekiguchi M, eds. Shinshu University Press, Matsumoto, pp. 314-324.
27. Wu TY, Li WS, Ge RL, et al. (1998a). Epidemiology of chronic mountain sickness. Ten years study in Qinghai,Tibet In: Progress in Mountain Medicine and High Altitude Physiology. H. Ohno, T. Kobayashi, S. Masuyama, and M. Nakashima, eds. Press committee of the 3rd world congress on mountain medicine and high altitude physiology, Matsumoto, Japan, Matsumoto, Japan, pp. 120-125.
28. Wu TY, Tu DT, Zha GL, et al. (1998b). The physiologic difference between the Tibetans and the Andeans. In: Progress in Mountain Medicine and High Altitude Physiology. H. Ohno, T. Kobayashi, S. Masuyama, and M. Nakashima eds. Press committee of the 3rd world congress on mountain medicine and high altitude physiology, Matsumoto, Japan, pp. 190-194.
29. Wu TY, Li WS, Wei LY, et al. (1998c). A preliminary study on the diagnosis of chronic mountain sickness in Tibetan populations. In: Progress in Mountain Medicine and High Altitude Physiology. Ohno H, Kobayashi T, Masuyama S, and Nakashima M eds. Press committee of the 3rd world congress on mountain medicine and high altitude physiology, Matsumoto, Japan, pp. 337-342.
30. Wu TY, Miao CY, Li WS, et al. (1999). Determination of pulmonary arterial pressure in high altitude residents [in Chinese]. Chin J High Alt Med 9:- 8.
31. Xi AQ. (2000). Relationship between erythrocyte rheological properties and RBC superoxide dismutase and plasma malondialdehyde in patients with high altitude polycythemia. Chin J Pathophysiol (Chin) 16:412-414.
32. Xie CF, and Pei SX. (1981). Some physiological data on sojourners and indigenous highlanders at 3 different altitudes in Xizang. In: Geological and Ecological Studies of Qinghai-Xizang (Tibet) Plateau (Proc Symp Qinghai - Xizang (Tibet) plateau, Beijing, China, Vol. 2). Liu DS, ed. Gordon and Breach Press, New York, pp. 1449-1452.
33. Zhang XZ, Cui JG, and Cheng LS. (1999). A comparative study of free radical metabolism of youths in indigenous Tibetans and migrated Hans at 4300m. Chin J High Alt Med (Chin) 10:9-11.
34. Zhou XD, Yang YM, and Liu BW. (1983). A clinical observation on high altitude polycythemia treated with medroxyprogesterone [in Chinese]. Chin J Hematol 4:132-133.